CONMED CORP (CNMD)

US2074101013 - Common Stock

67.22  +1.44 (+2.19%)

After market: 67.22 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
1.011B
17.17%		1.046B
3.45%		1.245B
19.06%		1.377B
10.63%
EBITDA
YoY % growth
180.8M
34.82%		139.7M
-22.73%		193.277M
38.35%		279.37M
44.54%		N/A
EBIT
YoY % growth
110.1M
79.02%		70.1M
-36.33%		121.403M
73.19%		218.39M
79.89%
Operating Margin
10.89%6.70%9.75%15.86%
EPS
YoY % growth
3.21
48.61%		2.65
-17.45%		3.45
30.19%		4.42
28.14%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.99
19.80%
Revenue
Q2Q % growth		348.73M
9.77%
EBITDA
Q2Q % growth		64.593MN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		50.356M
83.78%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 0.79
19.70%		0.750.044.91%
Q4 2023
Q2Q % growth		 1.06
152.38%		1.13-0.07-6.38%
Q3 2023
Q2Q % growth		 0.90
16.88%		0.850.056.31%
Q2 2023
Q2Q % growth		 0.83
9.21%		0.810.022.44%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 327.045M
30.35%		338.84M-11.795M-3.48%
Q3 2023
Q2Q % growth		 304.6M
10.72%		306.93M-2.33M-0.76%
Q2 2023
Q2Q % growth		 317.7M
14.61%		312.21M5.49M1.76%
Q1 2023
Q2Q % growth		 295.5M
21.96%		272M23.5M8.64%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -17.79% 0% -1.58%
Revenue0% -1.99% 0% -0.36%